Yield10 Bioscience Inc (NASDAQ:YTEN) Sellers Rose By 2.23% Their Shorts As Of Jun 29, 2018

June 29, 2018 - By Arnold Ferreira

Yield10 Bioscience Inc (NASDAQ:YTEN) registered an increase of 2.23% in shares shorted. It was published in June by FINRA the 983,600 shares shorted on YTEN. Previously was reported up change of 2.23% from 962,100 shares. Yield10 Bioscience Inc (NASDAQ:YTEN) has 242,100 shares average volume. It’ll cost 4 days for YTEN to recover its previous position. Float short on Yield10 Bioscience Inc is 32.93%.

YTEN is reaching $1.4 during the last trading session, after decreased 1.40%.Yield10 Bioscience, Inc. has volume of 26,415 shares. Since June 29, 2017 YTEN has declined 61.43% and is downtrending. YTEN underperformed by 74.00% the S&P 500.

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States.The firm is worth $13.99 million. It is developing various yield traits using proprietary advanced biotechnology trait gene discovery platforms.Last it reported negative earnings. The firm was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017.

More recent Yield10 Bioscience, Inc. (NASDAQ:YTEN) news were announced by Nasdaq.com, Streetinsider.com and Streetinsider.com. The first one has “Yield10 Researchers Publish Research in Plant Cell Reports Describing the Development of its Camelina Platform as …” as a title and was announced on June 21, 2018. The next is “Yield10 Bioscience (YTEN) Researchers Publish Research in Plant Cell Reports Describing Development of its …” on June 21, 2018. And last was announced on June 26, 2018, called “Form S-1/A SELLAS Life Sciences”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: